DK160053B - PROCEDURE FOR MANUFACTURING NON-TOXIC STYRENE, ACRYLIC OR EPOXY RESIN WITH CHOLESTEROL-LOWERING PROPERTIES - Google Patents

PROCEDURE FOR MANUFACTURING NON-TOXIC STYRENE, ACRYLIC OR EPOXY RESIN WITH CHOLESTEROL-LOWERING PROPERTIES Download PDF

Info

Publication number
DK160053B
DK160053B DK335579A DK335579A DK160053B DK 160053 B DK160053 B DK 160053B DK 335579 A DK335579 A DK 335579A DK 335579 A DK335579 A DK 335579A DK 160053 B DK160053 B DK 160053B
Authority
DK
Denmark
Prior art keywords
resins
cholesterol
resin
concentration
catalyst
Prior art date
Application number
DK335579A
Other languages
Danish (da)
Other versions
DK335579A (en
DK160053C (en
Inventor
Hans Zemp
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK335579A publication Critical patent/DK335579A/en
Publication of DK160053B publication Critical patent/DK160053B/en
Application granted granted Critical
Publication of DK160053C publication Critical patent/DK160053C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/745Polymers of hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Steroid Compounds (AREA)

Description

DK l6 1 ηS3 BDK l6 1 ηS3 B

Den foreliggende opfindelse angår en fremgangsmåde til fremstilling af ikke-toxiske styren-, acryl- eller epoxyharpikser med cholesterolsænkende egenskaber.The present invention relates to a process for producing non-toxic styrene, acrylic or epoxy resins with cholesterol lowering properties.

55

Ionbytterharpikser har specielt fundet anvendelsen ved behandlingen af forskellige patologiske tilstande som f.eks. hyperaciditet, forhindring af Na+-mangel i mavetarmkanalen, induktion af K+-udskillelse, behandling af 10 nephrotisk-, pancreas- og cardiaødem, behandling af ulcus, neutralisering af mavesurhedstilstande osv.In particular, ion exchange resins have found utility in the treatment of various pathological conditions, e.g. hyperacidity, prevention of Na + deficiency in the gastrointestinal tract, induction of K + secretion, treatment of 10 nephrotic, pancreatic and cardiac edema, treatment of ulcer, neutralization of gastric acidity, etc.

Naturligvis kræver hver enkel patologisk tilstand en harpiks med specielle kemiske egenskaber valgt blandt svagt 15 sure harpikser, stærkt sure harpikser, svage basiske harpikser og stærke basiske harpikser, forudsat at disse harpikser ikke virker toxiske over for den menneskelige organisme.Of course, every single pathological condition requires a resin with special chemical properties selected from weakly acidic resins, highly acidic resins, weakly basic resins and strong basic resins, provided these resins do not appear toxic to the human organism.

20 Anvendelsen af ionbytterharpikser er specielt blevet udvidet i de senere år ved behandling af hyperlipemi. Det er en kendsgerning, at for høje niveauer af lipider, der i det væsentlige er cholesterol og triglycerider, kan forårsage tidlig arteriosclerose i organismen med følger 25 som f.eks. hjerteinfarkt og cerebraltrombose. Hyperlipemi er derfor et udstrakt problem, for hvilken det endelige lægemiddel endnu ikke er fundet.20 The use of ion exchange resins has been especially expanded in recent years in the treatment of hyperlipemia. It is a fact that too high levels of lipids that are essentially cholesterol and triglycerides can cause early arteriosclerosis in the organism with sequences such as heart attack and cerebral thrombosis. Hyperlipemia is therefore a widespread problem for which the final drug has not yet been found.

For at reducere cholesterol til normale niveauer, er det 30 nødvendigt både at undgå alle de næringsstoffer, der er rige på disse eller på mættede fedtstoffer, og samtidig forøge fjernelsen af cholesterol.In order to reduce cholesterol to normal levels, it is necessary both to avoid all the nutrients rich in these or to saturated fats, and at the same time to increase the removal of cholesterol.

Det har vist sig, at ionbytterharpikser af basisk karak-35 ter virker på en anden måde ved at binde galdesyrerne i tarmkanalen, hvorved den enterohepatiske recirkulation afbrydes med følgelig tab af cholesterol.It has been found that ionic exchange resins of basic character act in a different way by binding the bile acids in the intestinal tract, thereby interrupting the enterohepatic recirculation with consequent loss of cholesterol.

22

DK 16 f> O !:o BDK 16 f> O!: O B

For at udføre denne cholesterolfjernende metode i praksis er visse basiske anionbytterharpikser blevet fremstillet indeholdende amino- og/eller ammoniumgrupper, der er i stand til kemisk at binde galdesyrerne.In order to carry out this cholesterol-removing method in practice, certain basic anion exchange resins have been prepared containing amino and / or ammonium groups capable of chemically bonding the bile acids.

55

De hidtil fremstillede og anvendte harpikser er i det væsentlige Cholestyramin og Cholestypol. Den første af disse harpikser er i det væsentlige en styren harpiks, der indeholder kvarternære ammoniumgrupper tværbundet med 10 divinylbenzen, medens den anden er en polymer af N-(2-aminoethyl)-l,2-ethandiamin med chlormethyloxiran. Set ud fra et teoretisk synspunkt er den kemiske virkemåde af disse harpikser tilsyneladende klar, og kan derfor klart bestemmes ud fra et kvantitativt synspunkt, i praksis har 15 de opnåede resultater imidlertid været betydelig dårligere, end man kunne antage, og de kan forbedres. Specielt har disse harpikser ofte i modsætning til de resultater, der er opnået ved in vitro forsøg, uafhængigt af deres kemiske natur, for lav kapacitet til at binde cholationer 20 in vivo, fordi enten er den reduktion i cholesterol, de bevirker, ubetydelig, eller de skal anvendes i meget høje doser, hvilket forårsager alvorlige bivirkninger i mavetarmkanalen .The resins so far made and used are essentially Cholestyramine and Cholestypol. The first of these resins is essentially a styrene resin containing quaternary ammonium groups cross-linked with 10 divinylbenzene, while the second is a polymer of N- (2-aminoethyl) -1,2-ethanediamine with chloromethyloxirane. From a theoretical point of view, the chemical action of these resins is apparently clear and can therefore be clearly determined from a quantitative point of view, however, in practice, however, the results obtained have been considerably poorer than one might assume and can be improved. In particular, contrary to the results obtained in in vitro experiments, regardless of their chemical nature, these resins often have too low a capacity to bind cholesterol in vivo, because either the reduction in cholesterol they cause is negligible, or they must be used at very high doses, causing severe gastrointestinal side effects.

25 En hel nærliggende ting ville være at fremstille harpikser med en højere koncentration af funktionelle grupper. Imidlertid har det vist sig, at ved at forøge koncentrationen af harpiksens basiske funktionelle grupper over en vis grænse, hvad enten disse er stærke eller svage, redu-30 ceres deres aktivitet snarere end forøges. Det har imidlertid nu vist sig, at aktiviteten af harpiksen kun i begrænset omfang afhænger af den kemiske art og antallet af de basiske funktionelle tilstedeværende grupper, medens den bestemmende faktor er "tilgængeligheden" af de 35 funktionelle grupper for galdesyremolekylerne, der som bekendt alle er forbindelser af steroid opbygning og derfor umådelig voluminøse og med lav mobilitet.25 A very obvious thing would be to produce resins with a higher concentration of functional groups. However, it has been found that by increasing the concentration of the basic functional groups of the resin over a certain limit, whether strong or weak, their activity is reduced rather than increased. However, it has now been found that the activity of the resin depends only to a limited extent on the chemical nature and number of basic functional groups present, while the determining factor is the "availability" of the 35 functional groups for the bile acid molecules, which are known all compounds of steroid build-up and therefore immensely bulky and with low mobility.

DK 160(1'->3 BDK 160 (1 '-> 3 B

33

Den umiddelbare løsning på problemet ville derfor synes at være at anvende lineære opløselige harpikser, hvis funktionelle grupper antages at have maksimum tilgængelighed.The immediate solution to the problem would therefore appear to be to use linear soluble resins whose functional groups are assumed to have maximum availability.

55

Det har imidlertid vist sig, at anioniske harpikser af denne type fuldstændig uventet er i besiddelse af meget ringe aktivitet, på grund af at de lineære kæder, som ikke er bundet sammen, agglomererer i et vandigt miljø især 10 på grund af koordinationsbindinger under dannelse af et fuldstændigt randomiseret pseudogitterværk, i hvilket det er praktisk taget umuligt for de store galdesyremolekyler at trænge ind, og dette fjerner derfor de fleste af de aktive grupper fra ionbytterreaktionen.However, it has been found that anionic resins of this type are completely unexpectedly in possession of very little activity, because the linear chains which are not bonded together agglomerate in an aqueous environment, in particular due to coordination bonds forming a completely randomized pseudogitter grid in which it is practically impossible for the large bile acid molecules to penetrate, and this therefore removes most of the active groups from the ion exchange reaction.

15 På samme måde har meget kraftigt tværbundne harpikser en meget lav og utilstrækkelig aktivitet på grund af dannelsen af et for snævert gitterværk, der ikke er tilgængeligt for galdesyremolekylerne.Similarly, very strongly crosslinked resins have a very low and insufficient activity due to the formation of a too narrow lattice mill that is not available to the bile acid molecules.

2020

Man har nu fundet, at der kan opnås cholesterol sænkende anionbytterharpikser med meget høj aktivitet ved at fremstille harpikser, der har en almindelig tværbindingsgrad, der holdes inden for meget veldefinerede kritiske græn-25 ser, og som er forskellige for hver type harpiks.It has now been found that cholesterol-lowering anion exchange resins with very high activity can be obtained by producing resins which have a common degree of crosslinking which are within very well defined critical limits and which are different for each type of resin.

Hensigten med den almindelige tværbinding ved fremgangsmåden ifølge opfindelsen er at danne "masker" i den polymere, der har en åbning, der i det væsentlige "svarer 30 til" rumfanget af galdesyrerne, der således kan komme i kontakt i fordøjelseskanalen med det højst mulige antal aktive funktionelle grupper.The purpose of the common crosslinking of the process of the invention is to form "masks" in the polymer having an aperture substantially "equal to" the volume of the bile acids, which can thus contact the digestive tract with the highest possible number. active functional groups.

Da funktionelle grupper af forskellig kemisk art har for-35 skelligt volumen og derfor skaber forskellig grad af "modstand" og sterisk hindring inden i "maskerne", er det klart, at den kritiske effektive grad af tværbinding erSince functional groups of different chemical species have different volumes and therefore create different degrees of "resistance" and steric hindrance within the "masks", it is clear that the critical effective degree of crosslinking is

4 DK 16 O O Η 3 B4 DK 16 O O Η 3 B

forskellig afhængig af harpiksens kemiske art. Imidlertid afhænger det på ingen måde af om harpiksen har en gel-agtig, mikroporøs eller makroporøs opbygning.different depending on the chemical nature of the resin. However, it does not in any way depend on whether the resin has a gel-like, microporous or macroporous structure.

5 For en lineær polymer af en forud bestemt kemisk art og med et vist antal basisk aktive grupper, dvs. en polymer med en ionbytterevne, fås hermed en forud bestemt chole-sterolsænkende virkning ved i denne at frembringe en nøjagtig grad af ensartet tværbinding.For a linear polymer of a predetermined chemical species and with a certain number of basic active groups, i. a polymer having an ion exchange capacity is thereby obtained a predetermined cholesterol lowering effect by producing an accurate degree of uniform crosslinking.

1010

For at opnå denne grad af tværbinding og som følge heraf den krævede åbning af maskerne dannet i polymeren, skal den tværbindende monomer i blandingen af monomere, der skal polymeriseres, anvendes i en nøjagtig defineret pro-15 centdel.To achieve this degree of cross-linking and, as a result, the required opening of the meshes formed in the polymer, the cross-linking monomer in the mixture of monomers to be polymerized must be used in a precisely defined percentage.

For at opnå ensartet tværbinding og som følge heraf en ensartet størrelse af maskerne dannet i polymeren, skal der anvendes en meget lav polymeringshastighed ved at ud-20 vælge katalysatoren, reaktionstemperaturen, monomerkon centration i reaktionsopløsningen og katalysatorkoncentrationen på passende måde.In order to achieve uniform cross-linking and, as a result, a uniform size of the meshes formed in the polymer, a very low polymerization rate must be used by selecting the catalyst, reaction temperature, monomer concentration in the reaction solution and the catalyst concentration appropriately.

Det har vist sig, at de mest velegnede katalysatorer til 25 at tilvejebringe de nødvendige milde polymeringsbetingel- ser er organiske peroxider og specielt lauroyl- og ben-zoylperoxid. Det foretrækkes at anvende benzoylperoxid, fordi det har en højere halveringstid og en bedre renhed og katalysatorevne.It has been found that the most suitable catalysts for providing the necessary mild polymerization conditions are organic peroxides and especially lauroyl and benzoyl peroxide. It is preferred to use benzoyl peroxide because it has a higher half-life and a better purity and catalyst performance.

3030

De kritiske betingelser under hvilke katalysatorerne skal anvendes til at fremstille de omhandlede harpikser er: 35The critical conditions under which the catalysts are to be used to prepare the resins in question are:

DK 16i ni)3 BDK 16i ni) 3 B

55

Lauroylperoxid - Acryl: temperatur 55-65°C; koncentration 1-2% - Styren: temperatur 60-70°C; koncentration 1-3% 5 - Epoxy: temperatur 55-65°C; koncentration 0,5-1,5%Lauroyl Peroxide - Acrylic: temperature 55-65 ° C; concentration 1-2% - Styrene: temperature 60-70 ° C; concentration 1-3% 5 - Epoxy: temperature 55-65 ° C; concentration 0.5-1.5%

Benzoylperoxid - Acryl: temperatur 60-70°C; koncentration 0,2-1,5% 10 - Styren: temperatur 65-75°C; koncentration 0,3-1,5% - Epoxy: temperatur 60-70°C; koncentration 0,2-1,0%Benzoyl Peroxide - Acrylic: temperature 60-70 ° C; concentration 0.2-1.5% 10 - Styrene: temperature 65-75 ° C; concentration 0.3-1.5% - Epoxy: temperature 60-70 ° C; concentration 0.2-1.0%

Det har også vist sig, at visse ikke særlig let kontrollerbare bireaktioner på de forskellige trin af de for-15 skellige processer kan forårsage yderligere tværbinding af polymernettet. Dette kan ødelægge hele den omhyggelige opbygning af harpiksen, hvis der ikke kontrolleres grundigt nok.It has also been found that certain not very easily controllable side reactions at the various stages of the various processes can cause further cross-linking of the polymer network. This can ruin the entire careful construction of the resin if not checked thoroughly enough.

20 Specielt når det drejer sig om acrylharpikser, kan denne uønskede reaktion ske under ammonieringsstadiet, hvor polyaminerne anvendes.Especially in the case of acrylic resins, this undesirable reaction may occur during the ammonia stage where the polyamines are used.

Når det gælder styrenharpikser, er det kritiske trin un-25 der chlormethyler ingen. Når det drejer sig om epoxyharpikser, er det vanskelige trin amineringen, når der anvendes polyaminer.In the case of styrene resins, the critical step under which chloromethyler is none. In the case of epoxy resins, the difficult step is the amination when using polyamines.

Det har vist sig, at disse uheldige reaktioner kan undgås 30 på følgende måde: - Acryl: ved ammonieringstrinnet, skal anvendes et stort overskud af polyaminer indtil 6 til 7 gange den støkiometriske mængde, 35 - Styren: ved chlormethyleringstrinnet anvendes en mild katalysator som f.eks. ZnC^ under meget svage betingelser, dvs. et fortyndet system ved lav temperatur (35-It has been found that these adverse reactions can be avoided in the following way: - Acrylic: at the ammonia step a large excess of polyamines up to 6 to 7 times the stoichiometric amount must be used, 35 - The styrene: at the chloromethylation step a mild catalyst such as .g. ZnC 2 under very weak conditions, i.e. a low temperature diluted system (35-

DK 160053 BDK 160053 B

6 40 °C), - Epoxy: ved amineringstrinnet anvendes et overskud af polyamin ved lav temperatur (35-40 °C).6 40 ° C) - Epoxy: at the amination step an excess of polyamine is used at low temperature (35-40 ° C).

5 Hvad angår valget af tværbindingsmiddel kan teoretisk alle molekyler, der har to vinylfunktioner, og som har en stor afstand mellem disse, anvendes som tværbindende middel. I praksis anvendes følgende: divinylbenzen, divinyltoluen, divinylxylen, divinylethylbenzen og lignende. Di-10 vinylbenzen foretrækkes på grund af dens reaktivitet, og da den er let tilgængelig.As regards the choice of crosslinking agent, theoretically all molecules having two vinyl functions and having a large distance between them can be used as crosslinking agents. In practice, the following are used: divinylbenzene, divinyltoluene, divinylxylene, divinylethylbenzene and the like. Di-vinylbenzene is preferred because of its reactivity and because it is readily available.

Det har nu uventet vist sig, at de faktorer, der bestemmer den cholesterolsænkende virkning af en ånionbytter-15 harpiks og specielt størrelsen af de tværbundne "masker", der findes i den, er en funktion af den tilsyneladende massefylde i vand og harpiksens absorptionsevne for vand, af hvilken grund maksimumaktiviteten for en vilkårlig harpiks svarer til en i det væsentlige konstant tilsyne-20 ladende massefylde og en i det væsentlige konstant vandabsorptionsevne .It has now unexpectedly been found that the factors that determine the cholesterol-lowering effect of an ion exchange resin and, in particular, the size of the cross-linked "masks" contained therein, are a function of the apparent density in water and the absorbency of the resin for water, for which reason the maximum activity of any resin corresponds to a substantially constant apparent density and a substantially constant water absorption capacity.

Opfindelsen angår således en fremgangsmåde til fremstilling af ikke-toxiske styren-, acryl- eller epoxyharpikser 25 med cholesterolsænkende virkning, der er ejendommelig ved det i kravets kendetegnende del angivne.The invention thus relates to a process for the production of non-toxic styrene, acrylic or epoxy resins 25 with cholesterol-lowering effect, which is characterized by the characterizing part of the claim.

Den specielle og konstante værdi for tilsyneladende massefylde og vandabsorptionsevne svarer for hver harpiks 30 til forud bestemte kombinationer af ionbytterevne og grad af tværbinding (udvalgt inden for et kritisk og nøjagtigt defineret område), og som derfor kan fastsættes entydigt for hver harpiks.The special and constant value for apparent density and water absorption ability, for each resin 30, corresponds to predetermined combinations of ion exchange capacity and degree of crosslinking (selected within a critical and accurately defined range) and can therefore be uniquely determined for each resin.

35 Til det foreliggende formål er den tilsyneladende massefylde i vand blevet bestemt, og den er defineret ved følgende metode:For the present purpose, the apparent density in water has been determined and is defined by the following method:

DK i * ", ·, 3 BDK i * ", ·, 3 B

7 20 g tør harpiks (tørret ved 40 °C i en vakuumovn indtil dens vægt er konstant) anbringes i 150-200 ml vand i 24 timer, idet der af og til omrøres. Herefter overføres harpiksen til en glassøjle, der er nøjagtig inddelt og 5 udstyret med en porøs bund.7 20 g of dry resin (dried at 40 ° C in a vacuum oven until its weight is constant) is placed in 150-200 ml of water for 24 hours, stirring occasionally. Then the resin is transferred to a glass column which is precisely divided and equipped with a porous base.

Herefter ekspanderes harpikslejet i modstrøm, idet vand tilledes i en mængde på 10 volumen pr. volumen harpiks, indtil man får et lag på 1 til 2 cm over harpiksen.Thereafter, the resin bed is expanded countercurrently, with water being supplied in an amount of 10 volumes per unit volume. volume of resin until a layer of 1 to 2 cm above the resin is obtained.

1010

Efter henstand i 20 minutter, bestemmes rumfanget af harpikslaget. Denne måling gentages to eller tre gange for hver prøve, således at fejlen falder indenfor 1%. Massefylden udtrykkes ved forholdet mellem harpiksens tørvægt 15 og dens rumfang i vand.After standing for 20 minutes, the volume of the resin layer is determined. This measurement is repeated two or three times for each sample so that the error falls within 1%. The density is expressed by the ratio of the dry weight of the resin 15 to its volume in water.

Vandabsorptionskapaciteten af harpiksen bestemtes altid på følgende måde: 20 3 g harpiks, der var tørret til konstant vægt ved en tem peratur på 40 °C under reduceret tryk, anbringes på en glasplade i en atmosfære, der er mættet ved fugtighed ved 25 °C, indtil der ikke sker yderligere vægtforøgelse.The water absorption capacity of the resin was always determined as follows: 20 g of resin, dried to constant weight at a temperature of 40 ° C under reduced pressure, was placed on a glass plate in an atmosphere saturated with humidity at 25 ° C. until no further weight gain occurs.

25 Det absorberede vand udtrykkes som en procentdel af totalvægten.25 The absorbed water is expressed as a percentage of the total weight.

Den cholesterolsænkende virkning af harpikserne bestemtes ved følgende måde in vitro: 30 20 ml natriumcholatopløsning med en koncentration på 2 mg/ml i en 0,02 molær opløsning af phosphatbuffer (pH 5) anbringes i en konisk kolbe.The cholesterol-lowering effect of the resins was determined in vitro as follows: 30 ml of sodium cholate solution at a concentration of 2 mg / ml in a 0.02 molar solution of phosphate buffer (pH 5) was placed in a conical flask.

35 1 ml vand og 30 mg harpiks sættes til kolben.35 ml of water and 30 mg of resin are added to the flask.

DK 160053 BDK 160053 B

88

Efter omrøring i 5 minutter ved 25 °C, filtreres indholdet, og den ikke bundne cholsyre bestemmes ved en spek-trofotometrisk metode efter omsætning med svovlsyre (Kier et al. J. Chim. Invest 40,755, 1952).After stirring for 5 minutes at 25 ° C, the contents are filtered and the unbound cholic acid is determined by a spectrophotometric method after reaction with sulfuric acid (Kier et al. J. Chim. Invest 40,755, 1952).

55

Aktiviteten udtrykkes ved den bundne natriumcholat i løbet af et vist tidsrum. Forskellige prøver af styren-, acryl- og epoxyharpikser fremstilledes med forskellig ombytningsevne og forskellig tværbindingsgrad.The activity is expressed by the bound sodium cholate over a certain period of time. Different samples of styrene, acrylic and epoxy resins were prepared with different exchangeability and different degree of crosslinking.

1010

Under anvendelse af de oven for beskrevne metoder bestemte den tilsyneladende massefylde, vandabsorptionen og aktiviteten for hver harpiks. Maksimumaktivitet opnåedes konstant med harpikser, der havde en tilsyneladende mas-15 sefylde på 0,18 til 0,20 g tørt materiale/ml og en vandabsorptionsevne på 69 til 73 vægt-%.Using the methods described above, they determined the apparent density, water absorption and activity of each resin. Maximum activity was constantly achieved with resins having an apparent density of 0.18 to 0.20 g dry matter / ml and a water absorbency of 69 to 73 wt%.

Ved denne metode bestemtes det kritiske område for ion-bytterevne og tværbindingen, indenfor hvilket det er mu-20 ligt at opnå en meget kraftig cholesterolsænkende virkning for en vilkårlig type af harpiks. Under anvendelse af denne metode, fandtes det, at i virkeligheden havde alle hidtil kendte harpikser, og som har en utilstrækkelig aktivitet til at kunne betragtes som et effektivt 25 cholesterolsænkende middel, en tilsyneladende massefylde i vand, der ligger uden for grænserne 0,18 til 0,20 g tørt materiale/ml, og specielt en massefylde og vandabsorption, der angiver dårlig ikke-ensartet tværbinding ("Cholestyramin"-typen) eller en for stor og ikke-30 ensartet tværbinding (Lewatit® MP 500 og "Cholestypol”-typer af harpiks).This method determined the critical range of ion exchange ability and crosslinking within which it is possible to obtain a very potent cholesterol lowering effect for any type of resin. Using this method, it was found that, in fact, all previously known resins and which have insufficient activity to be considered an effective cholesterol-lowering agent have an apparent density in water that is outside the range of 0.18 to 0.20 g dry matter / ml, and in particular a density and water absorption indicating poor non-uniform cross-linking (the "Cholestyramine" type) or an excessive and non-uniform cross-linking (Lewatit® MP 500 and "Cholestypol" - types of resin).

Den stærke ionbytterevne og den totale ionbytterevne bestemtes ligeledes for hver harpiks.The strong ion exchange capacity and total ion exchange capacity were also determined for each resin.

Den stærke ionbytterevne bestemtes på følgende måde: 10 g tør harpiks omdannedes til OH ved at perkolere en 5% 35 9The strong ion exchange capacity was determined as follows: 10 g of dry resin was converted to OH by percolating a 5% 35 9

DK 6η O 53BDK 6η O 53B

vandig NaOH opløsning, indtil der ikke længere fandtes Cl ioner i eluatet.aqueous NaOH solution until C1 ions were no longer present in the eluate.

Harpiksen vaskedes grundigt, indtil vandet var neutralt.The resin was washed thoroughly until the water was neutral.

5 OH formen genomdannedes til Cl ved at perkolere 400 ml af en 10% vandig NaCl opløsning, hvorefter der vaskedes med 1000 ml ^0. Den fundne base i eluatet filtreredes med 0,1 N HC1, idet 1 ml HC1 svarede til 0,01 milliækvi-valent pr. g (meq/g).The 5 OH form was genome-formed to Cl by percolating 400 ml of a 10% aqueous NaCl solution, then washing with 1000 ml of 0 The base found in the eluate was filtered with 0.1 N HCl, with 1 ml of HCl corresponding to 0.01 milliequivalent per ml. g (meq / g).

1010

Den totale ombytningsevne bestemtes på følgende måde: 10 g harpiks overførtes til OH-formen og den fri aminform som beskrevet ovenfor og behandledes med 100 ml IN HC1, hvorefter vaskedes med vand indtil neutral reaktion.The total interchangeability was determined as follows: 10 g of resin was transferred to the OH form and free amine as described above and treated with 100 ml of 1N HCl, then washed with water until neutral reaction.

15 HC1 af eluatet titreredes med 0,1N NaOH, idet man anvendte methylrødt som indikator.15 HCl of the eluate was titrated with 0.1N NaOH, using methyl red as indicator.

Den totale ombytningsevne af harpiksen angives ved det 20 antal milliækvivalenter syre, der ikke fandtes i eluatet, divideret med 10. De kritiske værdier, der bestemtes for de mest almindelige typer af de omhandlede anionbytter-harpikser og som er nødvendige for at opnå god choleste-rolsænkende virkning, er følgende: 25The total resilience of the resin is indicated by the 20 milliequivalents of acid not found in the eluate, divided by 10. The critical values determined for the most common types of the anion exchange resins concerned and necessary to obtain good cholesterol. anti-roll effect is as follows: 25

Styrenharpikser med amino- og ammoniumgrupperStyrene resins with amino and ammonium groups

Stærk ombytningsevne meq/g 2,8 - 4,0Strong interchangeability meq / g 2.8 - 4.0

Total ombytningsevne meq/g 2,8 - 4,0 30 Tværbindings-% 1,5 - 2,5Total exchangeability meq / g 2.8 - 4.0 Crosslink% 1.5 - 2.5

Acrylharpikser med amino- og ammoniumgrupper Stærk ombytningsevne meq/g 2,0 - 3,0Acrylic resins with amino and ammonium groups Strong interchangeability meq / g 2.0 - 3.0

Total ombytningsevne meq/g 5,5 - 8,0Total exchangeability meq / g 5.5 - 8.0

Tværbindings-% 10 - 12 35 Epoxyharpikser med amino- og ammoniumgrupperCrosslinking% 10 - 12 35 Epoxy resins with amino and ammonium groups

Stærk ombytningsevne meq/g 2-5Strong interchangeability meq / g 2-5

Total ombytningsevne meq/g 10 - 12,5Total exchangeability meq / g 10 - 12.5

Tværbindings-% 3-4Crosslink% 3-4

DK 160053 BDK 160053 B

10 Når det drejer sig om epoxyharpikser, angiver udtrykket "tværbinding" kun tværbindingen på grund af det tværbindende middel, idet der ses bort fra tværbindingen på grund af aminen.In the case of epoxy resins, the term "crosslinking" refers to the crosslinking only because of the crosslinking agent, ignoring the crosslinking due to the amine.

55

Nogle praktiske eksempler på de omhandlede cholesterol-sænkende harpikser er angivet nedenfor.Some practical examples of the subject cholesterol-lowering resins are given below.

EKSEMPEL 1 10EXAMPLE 1 10

Fremstilling af mikroporøs harpiks (AP2)Preparation of Microporous Resin (AP2)

En blanding bestående af 33 dele acrylnitril, 16 dele me-thylacrylat, 10 dele teknisk divinylbenzen (styrke 60%), 15 1 del benzoylperoxid og 40 dele toluen og opslæmmes under omrøring i en vandig opløsning indeholdende 20 vægt-% gelatine.A mixture consisting of 33 parts of acrylonitrile, 16 parts of methyl acrylate, 10 parts of technical divinylbenzene (strength 60%), 15 parts of benzoyl peroxide and 40 parts of toluene is suspended in aqueous solution containing 20% by weight of gelatin.

1 del bentonit sættes til suspensionen.One part of bentonite is added to the suspension.

2020

Suspensionen opvarmes i 40 timer ved 65 °C.The suspension is heated for 40 hours at 65 ° C.

Den således fremstillede polymer, der har form af opali-serende perler, vaskes omhyggeligt fra resten af den dis-25 pergerende opløsning. Porøsitetsmidlet fjernes ved dampdestillation, hvorefter polymeren tørres.The polymer thus obtained, in the form of opalescent beads, is carefully washed from the rest of the dispersing solution. The porosity is removed by steam distillation and the polymer is dried.

1 del polymer behandles med 5 dele ethylendiamin i 10 timer ved 130 °C. Efter afkøling fjernes overskuddet af 30 amin ved gentagen vask med vand. Det fremstillede produkt neddyppes i 50 dele 1^0 og 50 dele ^200^, afkøles til 0 °C og behandles med 400 dele CE^Br i 5 timer under omrøring .1 part polymer is treated with 5 parts ethylenediamine for 10 hours at 130 ° C. After cooling, the excess 30 amine is removed by repeated washing with water. The product obtained is immersed in 50 parts 1 0 and 50 parts 2 200 ^, cooled to 0 ° C and treated with 400 parts CE 2 Br for 5 hours with stirring.

35 Herefter filtreres, der vaskes med ^0, hvorefter der overføres til chloridformen i en perkolationssøjle ved langsomt at perkolere 1000 dele 5% vandig opløsning afThen filter, wash with ^ 0, then transfer to the chloride form in a percolation column by slowly percolating 1000 parts of 5% aqueous solution of

DK 1 6 O O S 3 BDK 1 6 O O S 3 B

1111

NaCl.NaCl.

Der fås en harpiks med følgende egenskaber: 5 Tværbinding 10%A resin is obtained with the following properties: 5 Crosslink 10%

Stærk ombytningsevne 2,1 meq/gStrong interchangeability 2.1 meq / g

Total ombytningsevne 6,2 meq/g H^O absorptionsevne 71%Total exchange capacity 6.2 meq / g H₂O absorbency 71%

Tilsyneladende massefylde 0,186 g/ml 10 Aktivitet 18 τ 0,4 mg bundet cholatApparent density 0.186 g / ml Activity 18 τ 0.4 mg bound cholate

Amin tertiær + kvaternær type EKSEMPEL 2 15 Fremstilling af en standard acrylharpiks (API)Amine Tertiary + Quaternary Type EXAMPLE 2 Preparation of a Standard Acrylic Resin (API)

En blanding bestående af 55 dele acrylnitril, 26,5 dele methylacrylat, 18,3 dele teknisk divinylbenzen (60%) og 0,2 dele benzoylperoxid opslæmmes under omrøring i en 20 vandig opløsning indeholdende 20 vægt-% gelatine. Der tilsættes suspensionen 2 dele bentonit. Suspensionen opvarmes ved 70°C i 40 timer.A mixture consisting of 55 parts of acrylonitrile, 26.5 parts of methyl acrylate, 18.3 parts of technical divinylbenzene (60%) and 0.2 parts of benzoyl peroxide is suspended with stirring in a 20 aqueous solution containing 20% by weight of gelatin. 2 parts of bentonite are added to the suspension. The suspension is heated at 70 ° C for 40 hours.

Den opnåede polymer vaskes, ammonieres, overføres til 25 kvarternær form og til chloridformen, således som beskrevet ovenfor.The polymer obtained is washed, ammoniated, transferred to 25 quaternary form and to the chloride form as described above.

Der fås en harpiks med følgende egenskaber: 30 Tværbinding 11%A resin is obtained with the following properties: 30 Crosslink 11%

Stærk ombytningsevne 2,1 meq/gStrong interchangeability 2.1 meq / g

Total ombytningsevne 6,1 meq/g H2O absorptionsevne 70,4%Total exchange capacity 6.1 meq / g H2O absorbency 70.4%

Tilsyneladende massefylde 0,192 g/ml 35 Aktivitet 18 τ 0,4 mg bundet cholatApparent density 0.192 g / ml Activity 18 τ 0.4 mg bound cholate

Amin tertiær + kvarternær type 12Amine tertiary + neighborhood near type 12

DK 1600S3BDK 1600S3B

EKSEMPEL 3EXAMPLE 3

Fremstilling af en standard styrenharpiks (S1) 5 En blanding bestående af 96,5 dele styren, 2,5 dele teknisk divinylbenzen (60%) og 1,0 del benzoylperoxid op-slæmmes under omrøring i en vandig opløsning indeholdende 15 vægt-% gelatine.Preparation of a Standard Styrene Resin (S1) .

10 Suspensionen tilsættes 0,5 dele bentonit.To the suspension is added 0.5 parts of bentonite.

Suspensionen opvarmes ved 70 °C i 40 timer.The suspension is heated at 70 ° C for 40 hours.

Den fremstillede polymer vaskes omhyggeligt fra resten af 15 den dispergerende opløsning og tørres.The prepared polymer is carefully washed from the rest of the dispersing solution and dried.

Herefter chlormethyleres hele produktet med monochlor-ether (200 dele) og zinkchlorid (65 dele) efter at det er ekspanderet i dichlorethan (300 dele), idet blandingen 20 opvarmes 7 timer ved 35 °C.Then the whole product is chloromethylated with monochloro ether (200 parts) and zinc chloride (65 parts) after it has been expanded in dichloroethane (300 parts), heating the mixture for 7 hours at 35 ° C.

Herefter amineres det opnåede mellemprodukt med tri-methylamin (180 dele af en 40% vandig opløsning) ved 45 °C i 6 timer.Thereafter, the intermediate obtained is aminated with trimethylamine (180 parts of a 40% aqueous solution) at 45 ° C for 6 hours.

2525

Den opnåede harpiks havde følgende egenskaber:The resin obtained had the following properties:

Tværbinding 1,5%Crosslink 1.5%

Stærk ombytningsevne 3,3 meq/g 30 Total ombytningsevne 3,3 meq/g H20 absorptionsevne 71,7%Strong exchange rate 3.3 meq / g 30 Total exchange rate 3.3 meq / g H2O absorbency 71.7%

Tilsyneladende massefylde 0,180 g/mlApparent density 0.180 g / ml

Aktivitet 15 τ 0,4 mg bundet cholatActivity 15 τ 0.4 mg bound cholate

Amin kvarternær type 35Amine quartersnear type 35

DK 1 ο-0ί,3 BDK 1 ο-0ί, 3 B

13 EKSEMPEL 4EXAMPLE 4

Fremstilling af en standard styrenharpiks (S^) 5 En blanding bestående af 95 dele styren, 3,5 dele teknisk divinylbenzen (styrke 60%) og 0,7 dele benzoylperoxid opslæmmes under omrøring i en vandig opløsning indeholdende 15% vægt-% gelatine.Preparation of a standard styrene resin (S 2) A mixture consisting of 95 parts styrene, 3.5 parts technical divinylbenzene (strength 60%) and 0.7 parts benzoyl peroxide is slurried with stirring in an aqueous solution containing 15% wt% gelatin.

10 Suspensionen tilsættes 0,7 dele bentonit.To the suspension is added 0.7 parts of bentonite.

Suspensionen opvarmes ved 70 °C i 40 timer.The suspension is heated at 70 ° C for 40 hours.

Den opnåede polymer vaskes, tørres, chlormethyleres og 15 amineres således som beskrevet i eksempel 3.The polymer obtained is washed, dried, chloromethylated and aminated as described in Example 3.

Man fik en harpiks der havde følgende egenskaber:A resin was obtained which had the following properties:

Tværbinding 2,1% 20 Stærk ombytningsevne 3,3 meq/gCrosslink 2.1% 20 Strong exchange rate 3.3 meq / g

Total ombytningsevne 3,3 meq/g absorptionsevne 71,5%Total exchange capacity 3.3 meq / g absorbency 71.5%

Tilsyneladende massefylde 0,195 g/mlApparent density 0.195 g / ml

Aktivitet 15 τ 0,4 mg bundet cholat 25 Amin kvarternær type EKSEMPEL 5Activity 15 τ 0.4 mg bound cholate 25 Amine quaternary type Example 5

Fremstilling af en standard epoxyharpiks () 30Preparation of a standard epoxy resin () 30

En blanding bestående af 93,3 dele epichlorhydrin, 6,5 dele teknisk divinylbenzen (styrke 60%) og 0,2 dele benzoylperoxid opslæmmes under omrøring i en vandig opløsning indeholdende 20 vægt-% gelatine.A mixture of 93.3 parts of epichlorohydrin, 6.5 parts of technical divinylbenzene (strength 60%) and 0.2 parts of benzoyl peroxide is slurried with stirring in an aqueous solution containing 20% by weight of gelatin.

Suspensionen opvarmes 40 timer ved 65 °C.The suspension is heated at 65 ° C for 40 hours.

35 1435 14

DK 160063 BDK 160063 B

Den fremstillede polymer vaskes omhyggeligt fra resten af det dispergerende system og tørres.The prepared polymer is carefully washed from the rest of the dispersing system and dried.

Hele polymeren behandles herefter med 100 dele ethylen-5 diamin og 40 dele NaOH-flager ved 65 °C i 10 timer under omrøring. Det fremstillede produkt vaskes med vand for at fjerne overskud af amin, hvorefter det nedsænkes i 50 dele ^0 og 50 dele Na2C0g, og der behandles med 500 dele CHgBr i 5 timer ved 0 °C under omrøring. Til slut filtre-10 res, der vaskes med vand, hvorefter der overføres til chloridformen i en perkolationssøjle ved langsomt at perkolere 1000 dele af en 5% vandig opløsning af NaCl.The entire polymer is then treated with 100 parts of ethylene-5 diamine and 40 parts of NaOH flakes at 65 ° C for 10 hours with stirring. The product obtained is washed with water to remove excess amine, then immersed in 50 parts of 50 and 50 parts of Na 2 CO 2 and treated with 500 parts of CH 2 Br for 5 hours at 0 ° C with stirring. Finally, wash, wash with water, then transfer to the chloride form in a percolation column by slowly percolating 1000 parts of a 5% aqueous solution of NaCl.

Der fås en harpiks med følgende egenskaber: 15A resin having the following properties is obtained:

Tværbinding 4%Crosslink 4%

Stærk ombytningsevne 2,1 meq/gStrong interchangeability 2.1 meq / g

Total ombytningsevne 10,5 meq/g H20 absorptionsevne 69,5% 20 Tilsyneladende massefylde 0,180 g/mlTotal exchange capacity 10.5 meq / g H2O absorbency 69.5% 20 Apparent density 0.180 g / ml

Aktivitet 12 τ 0,8 mg bundet cholatActivity 12 τ 0.8 mg of bound cholate

Amin tertiær + kvarternær type EKSEMPEL 6 25Amine tertiary + quaternary type EXAMPLE 6 25

Fremstilling af en standard epoxyharpiks (Eg) . <Preparation of a standard epoxy resin (Eg). <

En blanding bestående af 94,8 dele epichlorhydrin, 5 dele teknisk divinylbenzen (styrke 60%) og 0,2 dele benzoyl-30 peroxid opslæmmes under omrøring i en vandig opløsning indeholdende 20 vægt-% gelatine.A mixture of 94.8 parts of epichlorohydrin, 5 parts of technical divinylbenzene (strength 60%) and 0.2 parts of benzoyl peroxide is slurried with stirring in an aqueous solution containing 20% by weight of gelatin.

Suspensionen opvarmes 40 timer med 65 °C.The suspension is heated at 65 ° C for 40 hours.

35 Den fremstillede polymer vaskes, amineres og overføres til kvarternær form således som beskrevet i det tidligere eksempel.The polymer prepared is washed, aminated and transferred into quaternary form as described in the previous example.

DK 160053BDK 160053B

1515

Man fik en harpiks med følgende egenskaber:A resin having the following properties was obtained:

Tværbinding 3%Crosslink 3%

Stærk ombytningsevne 2,3 meq/g 5 Total ombytningsevne 10,9 meq/g H^O absorptionsevne 70,5%Strong exchange rate 2.3 meq / g 5 Total exchange rate 10.9 meq / g H 2 O absorbency 70.5%

Tilsyneladende massefylde 0,180 g/mlApparent density 0.180 g / ml

Aktivitet 12 τ 0,8 mg bundet cholatActivity 12 τ 0.8 mg of bound cholate

Amin tertiær + kvarternær type 10Amine tertiary + neighborhood near type 10

For nærmere at forklare de karakteristiske egenskaber ved de omhandlede harpikser er disse opsummeret i følgende tabel, hvor de er sammenlignet med de mest kendte kommercielle harpikser.In order to explain in more detail the characteristics of the resins in question, these are summarized in the following table, where they are compared with the most well-known commercial resins.

15 20 25 30 3515 20 25 30 35

DK 1600.43 BDK 1600.43 B

= >1=> 1

Η X OOΗ X OO

O OISLAND ISLAND

α a o o >ι φ w co is μ ^ v o w + · LO CM ID v -i-)α a o o> ι φ w co is μ ^ v o w + · LO CM ID v -i-)

(D · +> A r—I UD O(D · +> A r — I UD O

Η · +> Μ A co O O U (0 Λ 0) 0) > u w -μ x + « μ μ (U Η 00 μ is μ ^ o = o vo co co CO (0 V V V -I-) ID in CO ^ H o ^ μ λ vo oo μ < to κ > η χ <Μ VO 00Η · +> Μ A co OOU (0 Λ 0) 0)> your -µ x + «μ μ (U Η 00 μ is μ ^ o = o vo co co CO (0 VVV -I-) ID in CO ^ H o ^ μ λ vo oo μ <to κ> η χ <Μ VO 00

ft fi Vft fi V

s: φ ο ο μ οο ^3 ρ CM CM -η πω ιη ι ί οο ο η μ a cm id μ & μ φ φ j μ ο ο C0s: φ ο ο μ οο ^ 3 ρ CM CM -η πω ιη ι ί οο ο η μ a cm id μ & μ φ φ j μ ο ο C0

in Cin C

Α Φ in ο co s: μ is Η >i VO VO CM Ή) ^ ffl in co co vo o vdΑ Φ in ο co s: µ is Η> i VO VO CM Ή) ^ ffl in co co vo o vd

H A COH A CO

μ μ ία μ £ (0 φ > a χ οο c is o' •η d ^ E Φ σν σν ο ·η id μ «· - *.µ µ ία µ £ (0 φ> a χ οο c is o '• η d ^ E Φ σν σν ο · η id µ «· - *.

μ is cm cm cm in ο οο is μ vo μ w λ w φ μ ημ is cm cm cm in ο οο is μ vo μ w λ w φ μ η

η μ Sη μ S

ο id \ Λ > D) οχ ο ο μ = ''s s φ id σ σ ό η Φ φ η ο ε ε is λ 6¥> νμ ϋ Φ Φ Φ C C Φ C0 μ > > C CD Φ Φ Φ > Id Ό ω w φ ε α οι ο ω d d α d φ λ •η ·η ο Ό d φ ΰ ΰ ·η d Di > a ϋιμμμφε id is d Ν is a d d μ -ΗΛΰμΐΰμ ό ε ε ο η φ men d 0 0 ω φ μ * X -Η Ά d -Η Η ·Η Λ Η (d is > a α μ μ id ω -η μμ æ æ μ ο η μ (did > μ ο cm ·ηο id \ Λ> D) οχ ο ο μ = '' ss φ id σ σ ό η Φ φ η ο ε ε is λ 6 ¥> νμ ϋ Φ Φ CC Φ C0 μ>> C CD Φ Φ Φ> Id Ό ω w φ ε α οι ο ω dd α d φ λ • η · η ο Ό d φ ΰ ΰ · η d Di> a ϋιμμμφε id is d Ν is added μ -ΗΛΰμΐΰμ ό ε ε ο η φ men d 0 0 ω φ μ * X -Η Ά d -Η Η · Η Λ Η (d is> a α μ μ id ω -η μμ æ æ μ ο η μ (did> μ ο cm · η

id id E-icflEHtdE-tCid id E-icflEHtdE-tC

DK i n o b 3 BDK i n o b 3 B

•p μ (d• p µ (d

> CO> CO

x o - + oo o • >i co σι in h P X - ^·ι-)x o - + oo o •> i co σι in h P X - ^ · ι-)

p O CO <N O O O COd) Q ΓΗ O- CSp O CO <N O O O COd) Q ΓΗ O- CS

W -P 0) >-1W -P 0)> -1

•P• P

PP

(0 > 00 X o v(0> 00 X o v

+ 00 O+ 00 O.

. h in in h P X «. *. - » Ό. h in a h P X «. *. - »Ό

p O Ί M O O' O (Sp O Ί M O O 'O {S

D< H ID HD <H ID H

ω -p oω -p o

LOLO

• G σ> o• G σ> o

P 0) H CN (N in HP O) H CN (N in H

PP »· *> " * - 1-) (d>< oo co co h o inPP »· *>“ * - 1-) (d> <oo co co h o in

(N> -P IN H(N> -P IN H

Ui X (n oOnion X (n o

• C 00 V• C 00 V

PO) in co co in ho P P s s v - >.PO) in co co in ho P P s s v ->.

(0 >1 H CO 00 H O -Γ-) h> -p in m ω x ω h n.(0> 1 H CO 00 H O -Γ-) h> -p in m ω x ω h n.

Η HΗ H

* p o cs to cn ·>* p o cs to cn ·>

+ · Η Η rH O+ · Η Η rH O

• -P i—1 " >· » *• -P i — 1 "> ·» *

P P H CS VD O O TOP P H CS VD O O TO

i-HP (0 IN COi-HP (0 IN CO

Pu Φ > PPu Φ> P

< -P X<-P X

HH

>H ^ P -> H ^ P -

o ID Oo ID O

to co + · Η N Η ·ηto co + · Η N Η · η

. .p o «. *. 'OO. .p o «. *. 'ISLAND ISLAND

.p p Η N Ό H OH.p p Η N Ό H OH

CSP (0 INCSP (0 IN

O. <D > PO. <D> P.

< ·Ρ X Dl O (0<· Ρ X Dl O (0

\ S 0) H\ S 0) H

O’ D* Ό 0 0) (1) Η Λ S S >* o o¥> ΉO 'D * Ό 0 0) (1) Η Λ S S> * o o ¥> Ή

(D (1) d) -P(D (1) d) -P

G G Φ Φ (DG G Φ Φ (D

> > G (0 V>> G (0 V

d) d) > t0 Gd) d)> t0 G

a en Φ S o D dl 01 Λ G G G ® Η Η O Ό D) G dl C G H G >a and Φ S o D dl 01 Λ G G G ® Η Η O Ό D) G dl C G H G>

>a Cn-P-P-Pd) S> and Cn-P-P-Pd) S

(0 >1 c >1 >1 a Ό(0> 1 c> 1> 1 a Ό

G P Η Λ Λ P 10 PG P Η Λ Λ P 10 P

Ό S E O H (DΌ S E O H (D

co cd G o o ω d) Pco cd G o o ω d) P

η λ c -η HH Λ Η (0 >h >η λ c -η HH Λ Η (0> h>

DiQj pptd WHHDiQj pptd WHH

PP ffi fij P O H g PPP ffi fij P O H g P

(0(0 >PO NH N Ji a x E-ico^æE-icn<(0 (0> PO NH N Ji a x E-ico ^ æE-icn <

DK 160053 BDK 160053 B

1818

Den cholesterolsænkende virkning af de omhandlede harpikser undersøgtes også "in vivo".The cholesterol-lowering effect of the resins in question was also investigated "in vivo".

For at undersøge den "in vivo" cholesterolsænkende virk-5 ning af de forskellige harpikser, anvendtes følgende forsøg: 1) Deres virkning på hypercholesterolemi frembragt med en diæt med forøget cholesterolindhold hos rotter og kani- 10 ner.To investigate the "in vivo" cholesterol-lowering effect of the various resins, the following experiments were used: 1) Their effect on hypercholesterolemia produced by a diet with increased cholesterol content in rats and rabbits.

2) Deres virkning på fecal udskillelse af galdesyre hos hunde.2) Their effect on fecal secretion of bile acid in dogs.

15 1) For at inducere hypercholesterolemi hos rotter, hold tes dyrene på en diæt i overensstemmelse med, hvad der er beskrevet af Nath et al. (J.Nutrit 67, 289, 1959) indeholdende: 20 devitaminiseret casein 20% dl-methionin 0,4%1) To induce hypercholesterolemia in rats, animals are maintained on a diet according to what has been described by Nath et al. (J. Nutrit 67, 289, 1959) containing: 20 devitaminized casein 20% dl-methionine 0.4%

Hegsted saltvandsblanding 4% saccharose 49,1% cholesterol 1% 25 cholsyre 0,5% og vitaminerHegsted salt water mixture 4% sucrose 49.1% cholesterol 1% 25 cholic acid 0.5% and vitamins

For at inducere hypercholesterolemi hos kaniner, administreredes 1 g/dag/dyr cholesterol ved hjælp af en mave-sonde. Hver dyreart omfattede 84 handyr, nemlig rotter af 30 Spraque-Dawley stammen med en gennemsnitsvægt på 200 g og New Zealand kaniner på 3 kg, der opdeltes i 12 grupper med 7 dyr i hver. Alle dyrene sattes i en tilstand af hypercholesterolemi ved hjælp af foderet. En gruppe behandledes ikke, medens de andre 11 grupper behandledes med 35 0,5 g/kg en af harpikserne i 30 dage.To induce hypercholesterolemia in rabbits, 1 g / day / animal cholesterol was administered by a gastric probe. Each animal species comprised 84 male animals, namely, the 30 Spraque-Dawley strain rats weighing 200 g on average and New Zealand 3 kg rabbits divided into 12 groups of 7 animals each. All the animals were put into a state of hypercholesterolemia by the feed. One group was not treated while the other 11 groups were treated with 0.5 g / kg one of the resins for 30 days.

Harpikserne opløstes eller opslæmmedes i 10% gummiarabi- cumslim. Kun gummiarabicumslimen administreredes til kon trolgruppen.The resins were dissolved or suspended in 10% gum arabic adhesive. Only the gum arabic adhesive was administered to the control group.

10 DK 16 Η 3 Β 3 B10 DK 16 Η 3 Β 3 B

iy 5 På den 30. behandlingsdag aflivedes alle dyrene, og det totale plasmacholesterolindhold måltes i blodet opsamlet fra carotidarterierne (Pearson et al. J.Chim. Endocrin. Metabolism 12, 1245, 1952).On the 30th day of treatment, all animals were sacrificed and the total plasma cholesterol content was measured in the blood collected from the carotid arteries (Pearson et al. J. Chim. Endocrin. Metabolism 12, 1245, 1952).

10 2) For at vurdere den fecale udskillelse af galdesyre, anvendtes 48 han beagle-hunde, der vejede ca. 8 kg og som opdeltes i 12 grupper med fire dyr i hver gruppe. Alle dyrene holdtes på en standarddiæt under standardbetingelser og med undtagelse af kontrolgruppen af hunde fik 15 alle grupper ud over deres diæt 2 g/kg/dag af en af harpikserne i 25 dage. Fra den 26. dag fra begyndelsen af forsøget bestemtes galdesyrerne i feces fra hundene, der havde fastet 12 timer i en stofskiftekasse (Grundy et al., J. Lipid Res. 6, 397, 1965; Makita et al., Ann.10 2) To assess the fecal excretion of bile acid, 48 male beagle dogs were used, weighing approx. 8 kg and divided into 12 groups with four animals in each group. All animals were maintained on a standard diet under standard conditions and with the exception of the control group of dogs, 15 all groups in addition to their diet received 2 g / kg / day of one of the resins for 25 days. From the 26th day from the beginning of the experiment, the bile acids were determined in the feces of the dogs, which had fasted for 12 hours in a metabolic box (Grundy et al., J. Lipid Res. 6, 397, 1965; Makita et al., Ann.

20 Biochem. 5, 523, 1963; Forman et al., Clin.Chem. 14, 348, 1969).Biochem. 5, 523, 1963; Forman et al., Clin.Chem. 14, 348, 1969).

Tabel 1 og 2 opsummerer de opnåede resultater med rotter og kaniner bragt i hypercholesterolemisk tilstand via 25 diæten, og som er behandlet med forskellige harpikser.Tables 1 and 2 summarize the results obtained with rats and rabbits brought into hypercholesterolemic state via the diet and treated with various resins.

Den cholesterolsænkende virkning af de oralt administrerede harpikser i "in vivo" ligevægtsdoser stemte i det væsentlige overens med resultaterne fra "in vitro" for-30 søgene.The cholesterol-lowering effect of the orally administered resins in "in vivo" equilibrium doses was essentially consistent with the results of the "in vitro" experiments.

Med hensyn hertil fandt man atter, at når de omhandlede harpikser havde en tilsyneladende massefylde i vand på 0,18 til 0,20 g tørt materiale/ml og en vandabsorptions-35 evne på 69 til 73 vægt-% af polymervægten, så udviste de en cholesterolsænkende virkning både hos rotter og hos kaniner, som er overraskende større, end hvad der nogen-With regard to this, it was again found that when the resins in question had an apparent density in water of 0.18 to 0.20 g dry matter / ml and a water absorption capacity of 69 to 73% by weight of the polymer weight, they exhibited a cholesterol-lowering effect both in rats and in rabbits which is surprisingly greater than any

DK 16 O Ob3 BDK 16 O Ob3 B

20 sinde er blevet opnået med andre harpikser. Forskellen med hensyn til de tidligere kendte harpikser er alle højt signifikante (P>0,01).20 has been obtained with other resins. The difference with respect to the prior art resins is all highly significant (P> 0.01).

5 Tabel 3 viser galdesyreudskillelsesværdierne for hunde behandlet med 2 g/kg/dag med forskellige harpikser.5 Table 3 shows the bile acid excretion values for dogs treated with 2 g / kg / day with different resins.

Det fremgår klart, at når de omhandlede harpikser administreres, fremkommer der en betydelig forøgelse i den fe-10 cale galdesyreudskillelse i forhold til, hvad man hidtil har nået med de bedste harpikser, der er tilgængelige på nuværende tidspunkt. Højt signifikante forskelle (P>0,01) findes mellem galdesyreværdierne udskilt med feces efter administrering af AP£, AP^, S^, S2, E^ og og værdier 15 opnået med andre harpikser.It is clear that when the resins in question are administered, there is a significant increase in the fecal bile acid excretion compared to what has been achieved so far with the best resins available at present. Highly significant differences (P> 0.01) are found between the bile acid values excreted with faeces after administration of AP £, AP ^, S ^, S2, E ^ and and values 15 obtained with other resins.

20 25 30 35 2120 25 30 35 21

^ DK 160 053 B^ DK 160 053 B

m h in H IN H +1m h in H IN H +1

HH

C\J ~ <1- h in [x] IN H +1 cn ni o m in oo tn +iC \ J ~ <1- h in [x] IN H +1 cn ni o m in oo tn + i

(N(N

i—i <r * co in oo tn +1 mi — i <r * co in oo tn +1 m

Xi Hl H ·> p di IN <J\ O' (0 <! + z ^ c ni Q) CL) N σι <t u c Ό <D +1Xi Hl H ·> p di IN <J \ O '(0 <! + Z ^ c ni Q) CL) N σι <t u c Ό <D +1

0) CO0) CO

ex -ex -

*H H* H H

p α o dl U rv U (0 £ Ό Λ .μ tn 00 o to ni Ή 0) Q) IN H mp α o dl U rv U (0 £ Ό Λ .µ tn 00 o to ni Ή 0) Q) IN H m

. ? H. ? H

ht ‘jj o +i 03 H rj PH g P 03 -ht 'jj o + i 03 H rj PH g P 03 -

O XO X

d COd CO

p = h tn 1-1 n i2 <|G0 fn - . 9 4-1 æm nhn ® £ Ό f-i +l £1 U 0) “ s i: % æ h ρηι > in cdUD IN - Σ, g £ mp = h tn 1-1 n i2 <| G0 fn -. 9 4-1 äm nhn ® £ Ό f-i + l £ 1 U 0) “s i:% æ h ρηι> in cdUD IN - Σ, g £ m

O § Φ dj IN Η HO § Φ dj IN Η H

is -S +' ϊ Λ % HO ·Η O <1- o P O UD » n ø Cd in IN niis -S + 'ϊ Λ% HO · Η O <1- o P O UD »n ø Cd in IN ni

O 01 £ N Η HO 01 £ N Η H

£ cd Q)dj 3 Ό dl S +1£ cd Q) dj 3 Ό dl S +1

PP

0) O0) Oh

CO 00 CD H £h Η i>iCO 00 CD H £ h Η i> i

(0 P P(0 P P

P 18 M: O H (DØ E-ι Ό H S O ni o *h ni ~P 18 M: O H (DEE E-ι Ό H S O ni o * h ni ~

£! S IN H UD£! S IN H UD

O Cd = +1O Cd = +1

HH

OISLAND

U 00 P H *U 00 P H *

£ 00 UD£ 00 UD

o in ni h w +i d øo in ni h w + i d ø

PP

PP

o do d

HH

cdCD

PP

S I?S I?

DK 160053BDK 160053B

2222

OO <MOO <M

IO CT\IO CT \

H IS Η ISH IS Η IS

+ 1+ 1

CQ HCQ H

<t" CTv »<t "CTv"

H S H COH S H CO

+1+1

H CMH CM

CM tOCM tO

CO S H <f +1CO S H <f +1

CO COCO CO

H CM ·> cq is h ro +1H CM ·> cq is h ro +1

H CT\ LOH CT \ LO

A toA to

<3 S Η tO<3 S Η tO

+1+1

Φ I ,Α H SΦ I, Α H S

i A lo «3 0 < S H ro ο <Η , , S ^ - +'i A lo «3 0 <S H ro ο <Η,, S ^ - + '

-P Φ H-P Φ H

Φ S o u P< Ό -P h O Φ f.Φ S o u P <Ό -P h O Φ f.

0—1 I CQ0-1 in CQ

Ϊ3 Φ O CMΪ3 Φ O CM

iU c! c-! H ·> Φ CO o IS CM <1· β Λ £ •Η Φ ° +1 β -iU c! c-! H ·> Φ CO o IS CM <1 · β Λ £ • Η Φ ° +1 β -

COCO

il ω _= ιοil ω _ = ιο

Λ O «300 COΛ O «300 CO

cq od lo io cocq od lo io co

O φ H <t S ΙΟ HO φ H <t S ΙΟ H

Λ y *Λ y *

•H O ‘P CO• H O 'P CO

oi r ro -¾.¾ H - c. coco <f soi r ro -¾.¾ H - c. coco <f s

g -Π So, ^ ^ Hg -Π So, ^^ H

Η H -P +1 O 83 Φ β ·Η Φ Ό 1 (O, ,Ω -P β <83.Η H -P +1 O 83 Φ β · Η Φ Ό 1 (O,, Ω -P β <83.

CQ +3 φ -PCQ +3 φ -P

CO φ Φ CQ -HO „ H b0 ^ -P O 00CO φ Φ CQ -HO „H b0 ^ -P O 00

H O-H-HH O-H-H

ris! β P S <t Hrice! β P S <t H

S ,Q CO ^ S + EJ Η ΛS, Q CO ^ S + EJ Η Λ

β Oβ O

Φ β ΦΦ β Φ

cq φ bC Icq φ bC I

P -Η βP -Η β

H cq HH or H

CO Φ H -P- •P Η Φ m ~ O O X © © + ,CO Φ H -P- • P Η Φ m ~ O O X © © +,

^ ϋ cd H S <r H^ ϋ cd H S <r H

^ O -H O^ O -H O

i! S S CM lOin! S S CM 10

O COO CO

= +1= +1

rHrh

OISLAND

u <r -p σι - β ω ηu <r -p σι - β ω η

ο s CO CMο s CO CM

Μ +1 β φ β •Η §Μ +1 β φ β • Η §

XX

Η C0 -Ρ ££. β ΜΗ C0 -Ρ ££. β Μ

< S<S

roro

DK 160GH3BDK 160GH3B

2323

H 4 00 CDH 4 00 CD

4 O4 O

IA Hl CM + 4 w 4 o- cm co oIA Hl CM + 4 w 4 o- cm co o

ΙΑ HΙΑ H

CM +1CM +1

CMCM

co 4 iA σ cn oco 4 iA σ cn o

MO HMO H

CM +1CM +1

HH

mm

4 H IS4 H IS

ΙΑ HΙΑ H

IS HIS H

H CM +1H CM +1

Ph < 4 4 ooPh <4 4 oo

-4" H-4 "H

IS HIS H

4_> Al <D CM +14_> Al <D CM +1

-P HH-P HH

§ ^ 4 LA 4§ ^ 4 LA 4

2 OH2 OH

t . = S Ht. = S H

S U 3 w +l d ω 2 +l β w g 2 Λ I? 5 e ®S U 3 w + l d ω 2 + l β w g 2 Λ I? 5 e ®

S S O -4 CMS S O -4 CM

2 Λ Æ LA 4 Λ <D P H ^2 Λ Æ LA 4 Λ <D P H ^

O -HO -H

s I ss iA S ra H4 -i las I ss iA S ra H4 -i la

ML = Η IAML = Η IA

2 o r\ 3 ^ j_l H ^ % H +.2 o r \ 3 ^ j_l H ^% H +.

CO d Ta,0CO d Ta, 0

ω Μ g dSω Μ g dS

^ d bf dPn *4 -4 S^ d bf dPn * 4 -4 S

d * β JS © <f ω ή υΛ ..d * β JS © <f ω ή υΛ ..

Η Ώ Η ,Ο Η d % Η d Η ° Η d -ΡΟ πω Ι1^ -¾ -° ωΡπ -4 Ο Η d ω Η 00 3 δ , Η + 1 d-d Ρ ° la ^ cm 2 ® Η β Ο ·Η Λ Β 4 Ο Ο C0 Η Η = ΓΑ Ο CM Η Η +1 Ο β -Ρ β 4 00 ο s σ W CD ΙΑ + 1 0) d β 5 Η Μ cO \ -Ρ W) β οΗ Ώ Η, Ο Η d% Η d Η ° Η d -ΡΟ πω Ι1 ^ -¾ - ° ωΡπ -4 Ο Η d ω Η 00 3 δ, Η + 1 dd Ρ ° la ^ cm 2 ® Η β Ο · Β Λ Β 4 Ο C0 Η Η = ΓΑ Ο CM Η Η +1 Ο β -Ρ β 4 00 ο s σ W CD ΙΑ + 1 0) d β 5 Η cO \ -Ρ W) β ο

DK 160053BDK 160053B

2424

De ovenfor viste data angiver klart, at de omhandlede harpikser uafhængigt af matrixens kemiske natur og fysiske form (microporøs, macroporøs eller gel) effektivt er i stand til at binde galdesyrer, og at de bevirker en cho-5 lesterolsænkning, når de administreres peroralt, der er større, end hvad man hidtil har opnået med kendte harpikser.The data shown above clearly indicate that the resins in question, regardless of the chemical nature and physical form of the matrix (microporous, macroporous or gel), are effectively capable of binding bile acids and cause a cholesterol lowering when administered orally. that is greater than what has been achieved so far with known resins.

10 15 20 25 30 3510 15 20 25 30 35

Claims (1)

DK Vh'0d3B Patentkrav : Fremgangsmåde til fremstilling af ikke-toksiske styren-, 5 acryl- eller epoxyharpikser med cholesterol-spejl-sænkende egenskaber, kendetegnet ved, at enten A) polymeriseres styren langsomt med 1,5 - 2,5% divinyl-forbindelse (100%) i nærvær af lauroylperoxid som ka- 10 talysator i en koncentration på 1 - 3% ved temperatu rer mellem 60 og 70 °C, eller i nærvær af benzoylper-oxid som katalysator i en koncentration på 0,3 - 1,5% ved temperaturer på 65 og 75 °C, hvorpå det fremstillede produkt chlormethyleres i et fortyndet system ved 15 35 - 40 °C og derpå amineres, eller B) polymeriseres acrylmonomer langsomt med 10 - 12% af en divinylforbindelse (100%) i nærvær af lauroylperoxid som katalysator i en koncentration på 1 - 2% ved en 20 temperatur på mellem 55 og 65 °C, eller i nærvær af benzoylperoxid som katalysator i en koncentration på 0,2 - 1,5% ved en temperatur på mellem 60 og 70 °C, hvorpå det fremstillede produkt ammonieres og kvarter-niseres med indtil 2 gange den støkiometriske mængde 25 af polyamin, eller C) polymeriseres epiklorhydrin langsomt med 3 - 4% af en divinylforbindelse (100%) i nærvær af lauroylperoxid som katalysator i en koncentration på 0,5 - 1,5% ved 30 en temperatur på mellem 55 og 65 °C, eller i nærvær af benzoylperoxid som katalysator i en koncentration på 0,2 - 1% ved en temperatur på mellem 60 og 70 °C, hvorpå det fremstillede produkt amineres og kvarter-niseres med et overskud af polyamin ved 35 - 40 °C, hvorved der opnås et polymerisat med en bestemt og jævnt fordelt tværbindingsgrad, der udviser en tilsyneladende 35 DK 16 Π O b 3B massefylde i vand på 0,18 - 0,20 g tørt materiale/ml, og en vandabsorptionsevne på 69 - 73 vægt-% af den polymere vægt. 5 10 15 20 25 30 35DK Vh'0d3B Patent Claims: Process for the preparation of non-toxic styrene, 5 acrylic or epoxy resins with cholesterol-lowering properties, characterized in that either A) polymerizes styrene slowly with 1.5 - 2.5% divinyl. compound (100%) in the presence of lauroyl peroxide as a catalyst at a concentration of 1-3% at temperatures between 60 and 70 ° C, or in the presence of benzoyl peroxide as a catalyst at a concentration of 0.3 - 1 5% at temperatures of 65 and 75 ° C, whereupon the resulting product is chloromethylated in a diluted system at 35-40 ° C and then aminated, or B) slowly acrylic monomer is polymerized with 10-12% of a divinyl compound (100%). in the presence of lauroyl peroxide as a catalyst at a concentration of 1-2% at a temperature of between 55 and 65 ° C, or in the presence of benzoyl peroxide as a catalyst at a concentration of 0.2 - 1.5% at a temperature of between 60 and 70 ° C, whereupon the product obtained is ammoniated o g is quaternized with up to 2 times the stoichiometric amount of polyamine, or C) epichlorohydrin is slowly polymerized with 3-4% of a divinyl compound (100%) in the presence of lauroyl peroxide as a catalyst at a concentration of 0.5 - 1.5 % at 30 a temperature of between 55 and 65 ° C, or in the presence of benzoyl peroxide as a catalyst at a concentration of 0.2 - 1% at a temperature of between 60 and 70 ° C, at which the product produced is aminated and quaternized. with an excess of polyamine at 35 - 40 ° C to obtain a polymerisate having a definite and evenly distributed degree of cross-linking, which exhibits an apparent density of 0.18 - 0.20 g of dry material in water. / ml, and a water absorbency of 69-73% by weight of the polymeric weight. 5 10 15 20 25 30 35
DK335579A 1978-09-07 1979-08-10 PROCEDURE FOR MANUFACTURING NON-TOXIC STYRENE, ACRYLIC OR EPOXY RESIN WITH CHOLESTEROL-LOWERING PROPERTIES DK160053C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH938578 1978-09-07
CH938578A CH633186A5 (en) 1978-09-07 1978-09-07 Ion-exchange resins of the anionic type with hypocholesterolaemic properties

Publications (3)

Publication Number Publication Date
DK335579A DK335579A (en) 1980-03-08
DK160053B true DK160053B (en) 1991-01-21
DK160053C DK160053C (en) 1991-06-10

Family

ID=4351443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK335579A DK160053C (en) 1978-09-07 1979-08-10 PROCEDURE FOR MANUFACTURING NON-TOXIC STYRENE, ACRYLIC OR EPOXY RESIN WITH CHOLESTEROL-LOWERING PROPERTIES

Country Status (5)

Country Link
AT (1) AT383602B (en)
CH (1) CH633186A5 (en)
DK (1) DK160053C (en)
NO (1) NO155542C (en)
SE (1) SE445012B (en)

Also Published As

Publication number Publication date
DK335579A (en) 1980-03-08
DK160053C (en) 1991-06-10
NO155542C (en) 1987-04-15
AT383602B (en) 1987-07-27
ATA553079A (en) 1986-12-15
CH633186A5 (en) 1982-11-30
NO155542B (en) 1987-01-05
NO792600L (en) 1980-03-08
SE445012B (en) 1986-05-26
SE7906729L (en) 1980-03-08

Similar Documents

Publication Publication Date Title
US6844372B2 (en) Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
AU2019275584B2 (en) Proton-binding polymers for oral administration
US4393145A (en) Anionic ion exchange resins with cholesterol-decreasing properties
CA1104775A (en) Anionic microporous resin of hypocholesterolemising action
JP3113283B2 (en) Phosphate binding polymers for oral administration
US5667774A (en) Crosslinked polymeric ammonium salts
US6087300A (en) Method of producing material for purification of physiological liquids of organism
EP0157410B1 (en) Cholesterol level-lowering agents
US20090226392A1 (en) Phosphate-Binding Polymers for Oral Administration
AU2021245144A1 (en) Proton-binding polymers for oral administration
CA1171593A (en) Polyaminic resin for the selective separation of heparin from other glucosaminoglycanes and method for the preparation thereof
US4439419A (en) Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
WO1996021454A1 (en) Phosphate-binding polymers for oral administration
DK160053B (en) PROCEDURE FOR MANUFACTURING NON-TOXIC STYRENE, ACRYLIC OR EPOXY RESIN WITH CHOLESTEROL-LOWERING PROPERTIES
JP2010519298A (en) Amine polymer composition
GB2026501A (en) Anionic ion exchange resins with cholesterol-decreasing properties
JP2010520285A (en) Sulfone polymer composition
WO2010041274A2 (en) Process for the preparation of carbonate salts of cross-linked amine polymers
CN115400742A (en) Adsorption material and preparation method and application thereof
SU575363A1 (en) Method of obtaining ionites
SU768220A1 (en) Method of producing anion-exchange resins
MXPA97005305A (en) Phosphate fixing polymers for administration or

Legal Events

Date Code Title Description
PBP Patent lapsed